GE Healthcare Limited
- C01 - Terapia cardíaca
- RAPISCAN solution for injection 400 µg/5 ml
- V08 - Medios de contraste
- CLARISCAN PREFILLED SYRINGE solution for injection 279.3 mg/ml
- CLARISCAN solution for injection 279.3 mg/ml
- OMNIPAQUE solution for injection 302 mg (140 mg I)/ml
- OMNIPAQUE solution for injection 388 mg (180 mg I)/ml
- OMNIPAQUE solution for injection 518 mg (240 mg I)/ml
- OMNIPAQUE solution for injection 518 mg (240 mg I)/ml (polypropylene)
- OMNIPAQUE solution for injection 647 mg (300 mg I)/ml
- OMNIPAQUE solution for injection 647 mg (300 mg I)/ml (polypropylene)
- OMNIPAQUE solution for injection 755 mg (350 mg I)/ml
- OMNIPAQUE solution for injection 755 mg (350 mg I)/ml (polypropylene)
- OPTISON dispersion 0.66 mg/3 ml
- OPTISON dispersion 1 mg/ml
- V09 - Radiofármacos para diagnóstico
- DATSCAN solution for injection 185 MBq/2.5 ml
- MYOVIEW powder for solution for injection 0.23 mg
- V10 - Radiofármacos terapéuticos
- METASTRON solution for injection 150 MBq(4 mCi)/4 ml